Skip to main content

Table 1 Characteristics of participants (N=615)

From: Factors associated with suboptimal adherence to antiretroviral therapy in Viet Nam: a cross-sectional study using audio computer-assisted self-interview (ACASI)

Socio-demographic and behavioral characteristics

n

%

    Clinical characteristics

n

%

Sex (Female)

209

34.0%

    ART regimen 1

  

Age (Mean: 32.7± 6.2)

  

       d4T + 3TC + NVP

356

57.9%

  18–30

250

40.7%

       d4T + 3TC + EFV

165

26.8%

  31–40

301

48.9%

       AZT + 3TC + NVP

52

8.5%

  >=41

64

10.4%

       AZT + 3TC + EFV

17

2.8%

Education

  

       Others

25

4.1%

  <=Primary

57

9.3%

    Duration of ART (months) (Mean: 20.2±13.2)

  

  Secondary

301

39.7%

       <=12 months

201

32.7%

  High school

199

32.4%

       13–24 months

221

35.9%

  College or University

115

18.7%

       >24 month

193

31.4%

Occupation

  

    Tuberculosis treatment

  

  Unemployed

119

19.3%

       Ongoing

42

6.8%

  Salary-paid job

284

46.2%

       In the past

115

18.7%

  Others (farmer, labor works…)

212

34.5%

       Never

458

74.5%

Marital status

  

    Cotrimoxazole prophylaxis use

  

  Single

114

18.5%

       Ongoing

195

31.7%

  Married or live w partners

354

57.6%

       In the past

175

28.5%

  Divorced/separated/widow

147

23.9%

       Never

245

39.8%

Alcohol use (last month)

321

52.2%

    Facility location

  

Had >5 drinks (last month)

215

34.0%

       Rural

409

66.5

Illicit drug use (ever)

319

51.9%

       Urban

206

33.5

Illicit drug use (last month)

87

11.9%

    Administrative level of facility

  

Use of adherence aid

491

79.8%

       Provincial/City level

353

57.4

Depression

  

       District level

262

42.6

  No depressive symptoms

135

22.0%

    Distance from residence to clinic

  

  Mild depressive symptoms

334

54.3%

       <=10 km

302

49.1

  Major depressive symptoms

146

23.7%

       >10 km

313

50.9

  1. 1 d4T, stavudine; 3TC, lamivudin; NVP, nevirapine; EFV, efavirenz, AZT, zidovudine.